Insider · CIK 0002095962
Louis R. Verdetto
Files at SRTA (Strata Critical Medical, Inc.). First filing -, latest -.
Louis R. Verdetto files SEC Form 4 as CEO at SRTA (Strata Critical Medical, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Louis R. Verdetto has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | SRTA Strata Critical Medical, Inc. | FTax withholding Class A common stock, $0.0001 par value per share | -5,697 | $5.31 | $30k | 1,128,096 | 33 d ago |
| Dec 2, 2025 | SRTA Strata Critical Medical, Inc. | AGrant or award Class A common stock, $0.0001 par value per share | +63,918 | $0.00 | $0 | 1,133,793 | Dec 4, 2025 |
Questions about Louis R. Verdetto
Answered from the filings on this page, as of the latest one.
Is Louis R. Verdetto buying or selling?
Louis R. Verdetto has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Louis R. Verdetto's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Louis R. Verdetto has 0.
Where does Louis R. Verdetto file Form 4?
Louis R. Verdetto has filed Form 4 at SRTA (Strata Critical Medical, Inc.) as CEO Keystone Perfusion Service. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.